Literature DB >> 11376043

Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping.

S M Agwale1, K E Robbins, L Odama, A Saekhou, C Zeh, A Edubio, O M Njoku, N Sani-Gwarzo, M F Gboun, F Gao, M Reitz, D Hone, T M Folks, D Pieniazek, C Wambebe, M L Kalish.   

Abstract

The gp120 region of the human immunodeficiency virus type 1 (HIV-1) envelope (env) gene exhibits a high level of genetic heterogeneity across the group M subtypes. The heteroduplex mobility assay (HMA) has successfully been used to assign subtype classifications, but C2V5 primers often fail to amplify African strains. We developed an env gp41-based HMA for which the target sequence is amplified with highly conserved gp41 primers, known to efficiently amplify nucleic acids from HIV-1 group M, N, and O viruses. By using gp41 from a new panel of reference strains, the subtype assignments made by our modified HMA were concordant with those obtained by sequencing and phylogenetic analysis of 34 field strains from 10 countries representing subtypes A to G. Testing of field strains from Nigeria further demonstrated the utility of this modified assay. Of 28 samples, all could be amplified with gp41 primers but only 17 (60.7%) could be amplified with the standard C2V5 primers. Therefore, gp41-based HMA can be a useful tool for the rapid monitoring of prevalent subtypes in countries with divergent strains of circulating HIV-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376043      PMCID: PMC88097          DOI: 10.1128/JCM.39.6.2110-2114.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG.

Authors:  C Montavon; C Toure-Kane; F Liegeois; E Mpoudi; A Bourgeois; L Vergne; J L Perret; A Boumah; E Saman; S Mboup; E Delaporte; M Peeters
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

2.  A gag gene heteroduplex mobility assay for subtyping HIV-1.

Authors:  I D Tatt; K L Barlow; J P Clewley
Journal:  J Virol Methods       Date:  2000-06       Impact factor: 2.014

3.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.

Authors:  C L Kuiken; J J de Jong; E Baan; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

Authors:  L Heyndrickx; W Janssens; L Zekeng; R Musonda; S Anagonou; G Van der Auwera; S Coppens; K Vereecken; K De Witte; R Van Rampelbergh; M Kahindo; L Morison; F E McCutchan; J K Carr; J Albert; M Essex; J Goudsmit; B Asjö; M Salminen; A Buvé; G van Der Groen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.

Authors:  E C Holmes; L Q Zhang; P Simmonds; C A Ludlam; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  Fast and sensitive multiple sequence alignments on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Comput Appl Biosci       Date:  1989-04

7.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations.

Authors:  P Balfe; P Simmonds; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  HIV type 1 tat gene heteroduplex mobility assay as a tool to establish epidemiologic relationships among HIV type 1-infected individuals.

Authors:  R S Diaz; C F De Oliveira; R Pardini; E Operskalski; A J Mayer; M P Busch
Journal:  AIDS Res Hum Retroviruses       Date:  1999-09-01       Impact factor: 2.205

10.  Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.

Authors:  T F Wolfs; J J de Jong; H Van den Berg; J M Tijnagel; W J Krone; J Goudsmit
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

View more
  6 in total

1.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

2.  A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission Pairs.

Authors:  Olivier Manigart; Debrah I Boeras; Etienne Karita; Paulina A Hawkins; Cheswa Vwalika; Nathan Makombe; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-03       Impact factor: 2.205

3.  Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire.

Authors:  Souleymane Sawadogo; Christiane Adjé-Touré; Celestin E Bilé; Rene E A Ekpini; Terence Chorba; John N Nkengasong
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC.

Authors:  Min Wei; Qi Guan; Hao Liang; Jianping Chen; Zhao Chen; Faxin Hei; Yi Feng; Kunxue Hong; Hailong Huang; Hui Xing; Yiming Shao
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

5.  Use of the heteroduplex mobility assay and cell sorting to select genome sequences of the CCR5 gene in HEK 293T cells edited by transcription activator-like effector nucleases.

Authors:  Arildo Nerys-Junior; Lendel C Costa; Luciene P Braga-Dias; Márcia Oliveira; Atila D Rossi; Rodrigo Delvecchio da Cunha; Gabriel S Gonçalves; Amilcar Tanuri
Journal:  Genet Mol Biol       Date:  2013-02-28       Impact factor: 1.771

6.  Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.

Authors:  Georges Teto; Georgette D Kanmogne; Judith N Torimiro; George Alemnji; Flore N Nguemaim; Désiré Takou; Aubin Nanfack; Asonganyi Tazoacha
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.